Anna MARIA Buchberger

Dr. Anna MARIA Buchberger

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ABAnna MARIA Buchberger
Anna MARIA Buchberger
ESElmar Anton Strzelczyk
Elmar Anton Strzelczyk
Barbara WollenbergBarbara Wollenberg
Barbara Wollenberg
SCStephanie Combs
Stephanie Combs
APAnja Pickhard
Anja Pickhard
SPSteffi Pigorsch
Steffi Pigorsch
Regular tumor follow-up care provided by ear-nose-throat (ENT) specialists ends when patients reach 5-year survival, but radiotoxicity is a continuous lifelong process. In this study, long-term head-and-neck cancer (HNC) survivors undergoing tumor follow-up (FU) care exceeding five years in a certified HNC center of a German university hospital were analyzed for newly diagnosed late sequelae after radio-(chemo-)therapy. Patients diagnosed with squamous cell carcinoma (SCC) of the oral cavity, larynx or oro-/hypopharynx receiving treatment between 1990 and 2010 with a tumor FU care beyond five years were reviewed retrospectively for signs of late sequelae after radio-(chemo-)therapy (R(C)T) including carotid artery stenosis, stenosis of the cranial esophagus, dysphagia, osteoradionecrosis, and secondary malignancies. Long-term survivors that solely received surgical treatment served as control. Of 1143 analyzed patients we identified 407 patients with an overall survival beyond five years, 311 with R(C)T and 96 patients without R(C)T. Furthermore, 221/1143 patients were lost to FU and the mortality rate within the first 5-years was 45%. Moreover, 27.7% of the long-term survivors were diagnosed with new onset late sequelae within the following five years. RT was significantly associated with a two-fold risk increase for newly diagnosed symptoms, especially after RT of the lymphatic pathways (LP) which showed a hazard ratio of 23.3 to develop alterations on the carotid arteries. Additional chemotherapy had no statistical correlation with any late onset toxicity nor did the mode of R(C)T (adjuvant/definitive). Although the validity of this study might be limited due to its retrospective nature and the dependence on the voluntary participation in a prolonged tumor FU, the results nevertheless provide the need to offer and encourage a tumor FU by ENT specialists exceeding the common 5-year margin. This could prevent secondary morbidities and improve quality of life for long-term cancer survivors.

18 August 2021 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
SHStefan Hadas
Stefan Hadas
MHMaximilian Huhn
Maximilian Huhn
MRMichael Rentrop
Michael Rentrop
BWBarbara Wollenberg
Barbara Wollenberg
SCStephanie Combs
Stephanie Combs
ABAnna MARIA Buchberger
Anna MARIA Buchberger
Purpose: Cancer and morbidity during a therapeutic regimen can result in somatic and psychiatric impairment. We have evaluated the need of appropriate psychological screening by analyzing a large collective of head and neck cancer (HNC) patients with particularly burdensome symptoms. Methods: HNC-aftercare patients were asked about somatic and psychological symptoms by means of standardized questionnaires of the European Organization for Research and Treatment of Cancer (EORTC Q30 and QLQ-H&N35). Patients with poor well-being values on the World Health Organization-5-Well-Being Index were screened for depression by using the Mini International Neuropsychiatric Interview, and adequate treatment was initiated, if necessary. Results: Our sample consisted of 453 HNC-aftercare patients (average age 64.5 years; 72.0% male; 28.0% female). 25.1% showed abnormalities based on their WHO-5 questionnaire. A current major depressive episode was observed in 8.5% of the total study group. Patients with lip and oral cavity tumors showed the highest depression prevalence (18.9%). Time since initial HNC diagnosis showed no clear trend with regard to the number of depression cases. 50.0% of patients with a current major depressive episode consented to receiving assistance and/or therapy. Within the total study population, the most burdensome symptoms were found to be “dry mouth” (48.3%), “trouble doing strenuous activities” (46.0%), “trouble taking a long walk” (38.5%), and “worry” (35.5%). Aftercare patients with a depression diagnosis tended to have heavier symptom burdens than people without major depression. Conclusions: Despite the various cancer-related burdensome factors, prevalence levels of depression among the HNC-aftercare patients and the general population were similar. Nevertheless, since the number of diagnosed depression cases is high, the need for psychological treatment should be considered within the tumor collective. Furthermore, screening for depression should be implemented in clinical routines by using the appropriate standardized questionnaires.

1 May 2021 in The Laryngoscope
Verified
Journal Article
Open access
PDF file
ABAnna MARIA Buchberger
Anna MARIA Buchberger
RNRamona Nitiu
Ramona Nitiu
MPMelina Pinther
Melina Pinther
SGSimone Graf
Simone Graf
DSDaniel Skodacek
Daniel Skodacek
KSKatharina Storck
Katharina Storck
Objectives/Hypothesis Injection laryngoplasty of materials for unilateral vocal-fold paralysis has shown various results regarding the long-term stability of the injected material. We evaluated a fibrin-gel based cell suspension with autologous chondrocytes in-vitro and in-vivo as long-term-stable vocal-fold augmentation material in an animal model. Study Design This study compises an in vitro cell-culture part as well as an in vivo animal study with New Zealand White Rabbits. Methods In in-vitro experiments, auricular chondrocytes harvested from 24 New Zealand White Rabbits cadavers were cultivated in pellet cultures to evaluate cartilage formation for 4 weeks using long-term-stable fibrin gel as carrier. Injectability and injection volume for the laryngoplasty was determined in-vitro using harvested cadaveric larynxes. In-vivo 24 Rabbits were biopsied for elastic cartilage of the ear and autologous P1 cells were injected lateral of one vocal cord into the paraglottic space suspended in a long-term-stable fibrin gel. Histologic evaluation was performed after 2, 4, 12, and 24 weeks. Results During 12-week pellet culture, we found extracellular matrix formation and weight-stable cartilage of mature appearance. In-vivo, mature cartilage was found in two larynxes (n = 6) at 4 weeks, in four (n = 6) at 12 weeks, and in five (n = 6) at 24 weeks mostly located in the paraglottic space and sometimes with spurs into the vocalis muscle. Surrounding tissue was often infiltrated with inflammatory cells. Material tended to dislocate through the cricothyroid space into the extraglottic surrounding tissue. Conclusions A cell-based approach with chondrocytes for permanent vocal-fold augmentation has not previously been reported. We have achieved the formation of structurally mature cartilage in the paraglottic space, but this is accompanied by difficulties with dislocated material, deformation of the augmentation, and inflammation. Level of Evidence N/A Laryngoscope, 2020

14 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
OKOlena Klymenko
Olena Klymenko
ABAnna MARIA Buchberger
Anna MARIA Buchberger
Barbara WollenbergBarbara Wollenberg
Barbara Wollenberg
KWKlaus-Dietrich Wolff
Klaus-Dietrich Wolff
VKVictoria Kehl
Victoria Kehl
SPSteffi Pigorsch
Steffi Pigorsch
Purpose: We report the outcome of a mono-institutional retrospective study of sinonasal carcinoma with the primary focus on GTV (gross tumor volume) and the effect of radiotherapy. Methods: 53 patients with sinonasal carcinoma and that of the nasal cavity, paranasal sinus or both except lymphoma were included. All patients were treated between 1999 and 2017. For tumor volume delineation, all pre-therapeutic images were fused to the planning CT (computed tomography). Results: The median follow-up was 17 months [0.3–60], the median age 60 years, 35 males and 18 females were included. Squamous cell carcinoma (SCC) (60.4%) was the predominant histology, followed by adenocarcinoma (15.1%). The mean composite OS (overall survival) time was 33.3 ± 3.5 months. There was no significant difference in the 5 y composite OS between tumor localization or radiotherapy setting. The simultaneous integrated boost concept showed a trend towards improving five-year composite OS compared to the sequential boost concept. The only factor with a significant impact on the 5 y composite OS rate was the pre-therapeutic GTV (cutoff 75 cm3; p = 0.033). The GTV ≥ 100 cm3 has no effect on the 5 y composite OS rate for SCC. Conclusions: The pre-therapeutic GTV is a prognostic factor for five-year composite OS for the entire group of patients with sinonasal tumors, influencing the outcome after completion of all treatment strategies. The GTV seems to not influence five-year composite OS in SCC. For this rare tumor entity, an intensive, multidisciplinary discussion is essential to finding the best treatment option for the patient.

2 November 2017 in Otolaryngology Head and Neck Surgery
Verified
Journal Article
Open access
TMTechnical University Munich
Technical University Munich
ABAnna MARIA Buchberger
Anna MARIA Buchberger
PAPickhard A
Pickhard A
SKStorck K
Storck K
STStrenger T
Strenger T
STStark T
Stark T
Herald Scholarly Open Access publishes peer-reviewed scientific research which provides an immediate free access to articles. Herald Scholarly Open Access is publishing articles in 47 peer-reviewed Open Access journals in Biology, Medicine and Clinical sciences.

1 May 2020
Verified
Conference Paper
Open access
ABAnna MARIA Buchberger
Anna MARIA Buchberger
DUD Utz
D Utz
ADA Dierks
A Dierks
BWB Wollenberg
B Wollenberg
MSM Siegl
M Siegl
APA Pickhard
A Pickhard
Einleitung Bis dato werden sowohl Herkunft als auch Funktion mesenchymaler Stammzellen (MSC) im Tumormikromilieu (TME) kontrovers diskutiert. Adipogene Stammzellen (ASC) aus dem peritumoralen Fettgewebe könnten hierbei eine mögliche Stammzellquelle sein. Ziel der Arbeit war es, die Wechselwirkungen zwischen ASCs und Tumorzellen zu untersuchen. Material und Methode In Co-Kulturexperimenten mit HNSCC Zelllinien und peritumoralen sowie nicht tumorassoziierten primären ASC Zelllinien wurden durch Invasions-, Migrations- sowie Proliferationsassays die Wechselwirkungen untersucht. Mittels Elisa und PCR (IL-6, IL-20RA, IL-20RB, IL-22RA1, IL-24) wurden mögliche Mechanismen der gegenseitigen Beeinflussung gesucht. Zusätzlich wurde der Effekt einer 2Gy Bestrahlung (RTx) sowie die Stimulation durch IL-6 getestet. Ergebnisse Migrations- und Invasionsverhalten der ASCs war durch Co-Kultur mit HNSCCs signifikant stimulierbar. HNSCCs zeigten generell ein weniger invasives und migrierendes Verhalten. Nach einer RTx der Tumorüberstände nahmen ASC Invasivität und Migration deutlich ab, während die RTx der HNSCC Zelllinien teilweise sogar zur Zunahme der ASC Invasivität führte. Die Co-Kultivierung führte zu einem signifikanten Anstieg der Expression von IL-24 der HNSCCs während IL-20 RB deutlich reduziert wurde. ASCs zeigten hohe Expressionslevel für IL-6, welche zusätzlich durch 2Gy stimulierbar waren. Die Proliferation der HNSCCs war durch IL-6 hemmbar, das Expressionslevel von IL20-RB stimulierbar. Schlussfolgerung Die Invasivitäts- und Migrationszunahme von ASCs in Co-Kultur mit HNSCCs spricht für das peritumorale Fettgewebe als mögliche Stammzellquelle der tumorstämmigen MSCs. Das Verständnis der Rolle von ASCs im TME könnte neue therapeutische Ansätze eröffnen. Poster-PDF A-1341.PDF Publication Date: 10 June 2020 (online) © . © Georg Thieme Verlag KG Stuttgart · New York